LGM
Logos Global Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 47 |
|
|
2025
Q1 | – | Sell |
-500,000
| Closed | -$16M | – | 42 |
|
|
2024
Q4 | $16M | Buy |
+500,000
| New | +$16M | 1.87% | 20 |
|
|
2024
Q3 | – | Sell |
-400,000
| Closed | -$15.3M | – | 54 |
|
|
2024
Q2 | $15.3M | Sell |
400,000
-400,000
| -50% | -$15.3M | 1.23% | 18 |
|
|
2024
Q1 | $47M | Sell |
800,000
-150,000
| -16% | -$8.82M | 3.81% | 8 |
|
|
2023
Q4 | $56.9M | Buy |
950,000
+200,000
| +27% | +$12M | 5.31% | 3 |
|
|
2023
Q3 | $28.5M | Buy |
750,000
+125,000
| +20% | +$4.76M | 3.81% | 7 |
|
|
2023
Q2 | $56.9M | Sell |
625,000
-175,000
| -22% | -$15.9M | 7.74% | 1 |
|
|
2023
Q1 | $52.8M | Sell |
800,000
-550,000
| -41% | -$36.3M | 7.55% | 1 |
|
|
2022
Q4 | $69.8M | Buy |
1,350,000
+50,000
| +4% | +$2.59M | 8.18% | 2 |
|
|
2022
Q3 | $88.8M | Sell |
1,300,000
-200,000
| -13% | -$13.7M | 10.92% | 1 |
|
|
2022
Q2 | $67.8M | Buy |
1,500,000
+600,000
| +67% | +$27.1M | 12.44% | 2 |
|
|
2022
Q1 | $45.7M | Sell |
900,000
-100,000
| -10% | -$5.08M | 5.93% | 3 |
|
|
2021
Q4 | $47.3M | Sell |
1,000,000
-450,000
| -31% | -$21.3M | 4.88% | 5 |
|
|
2021
Q3 | $47.8M | Buy |
1,450,000
+1,100,000
| +314% | +$36.3M | 3.45% | 8 |
|
|
2021
Q2 | $22.1M | Buy |
+350,000
| New | +$22.1M | 1.86% | 19 |
|
|
2021
Q1 | – | Sell |
-300,000
| Closed | -$17.2M | – | 55 |
|
|
2020
Q4 | $17.2M | Buy |
+300,000
| New | +$17.2M | 1.47% | 13 |
|
|
2020
Q1 | – | Sell |
-587,108
| Closed | -$18M | – | 42 |
|
|
2019
Q4 | $18M | Buy |
+587,108
| New | +$18M | 4.43% | 5 |
|